R G Schlienger|M Saxer|W E Haefeli - JoVE Visualize

Showing results (41-50 of 131) with videos related to

Pageof 14

Sort By:

Intensive Care Medicine|January 1, 1992

Possible risk for cardiac arrhythmia related to intravenous erythromycinW E Haefeli, R A Schoenenberger, P Weiss, et al.

European Journal of Clinical Pharmacology|February 23, 1999

Xanthine oxidase inhibition by allopurinol affects the reliability of urinary caffeine metabolic ratios as markers for N-acetyltransferase 2 and CYP1A2 activitiesP Fuchs, W E Haefeli, H R Ledermann, et al.

Schweizerische Medizinische Wochenschrift|November 11, 1999

[Conviction as a basis for compliance and strategies for improving compliance]I Arnet, R A Schoenenberger, R Spiegel, et al.

Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis|December 8, 1992

[Drug-induced hyperprolactinemia and galactorrhea]M Bozzolo, W E Haefeli, G Noll, et al.

Journal of Vascular Surgery|April 18, 1998

Functional activity and transmembrane signaling mechanisms after cryopreservation of human internal mammary arteriesE Müller-Schweinitzer, P Stulz, H Striffeler, et al.

The Annals of Pharmacotherapy|January 6, 2001

Seizures associated with therapeutic doses of venlafaxine and trimipramineR G Schlienger, M H Klink, C Eggenberger, et al.

Journal of Vascular Surgery|April 1, 1997

Functional recovery of human mesenteric and coronary arteries after cryopreservation at -196 degrees C in a serum-free mediumE Müller-Schweinitzer, M J Mihatsch, M Schilling, et al.

Journal of Cardiovascular Pharmacology|May 1, 1990

Potent inhibition of cytochrome P450IID6 (debrisoquin 4-hydroxylase) by flecainide in vitro and in vivoW E Haefeli, M J Bargetzi, F Follath, et al.

British Journal of Pharmacology|May 24, 2000

The mechanism of cryoinjury: In vitro studies on human internal mammary arteriesE Müller-Schweinitzer, W Brett, H R Zerkowski, et al.

Pharmacoepidemiology and Drug Safety|April 26, 2007

Optimizing information on drug exposure by collection of package code information in questionnaire surveysR Quinzler, S P W Schmitt, J Szecsenyi, et al.

Pageof 14

Showing results (41-50 of 131) with videos related to

Sort By:

Pageof 14

Intensive Care Medicine|January 1, 1992

Possible risk for cardiac arrhythmia related to intravenous erythromycinW E Haefeli, R A Schoenenberger, P Weiss, et al.

European Journal of Clinical Pharmacology|February 23, 1999

Xanthine oxidase inhibition by allopurinol affects the reliability of urinary caffeine metabolic ratios as markers for N-acetyltransferase 2 and CYP1A2 activitiesP Fuchs, W E Haefeli, H R Ledermann, et al.

Schweizerische Medizinische Wochenschrift|November 11, 1999

[Conviction as a basis for compliance and strategies for improving compliance]I Arnet, R A Schoenenberger, R Spiegel, et al.

Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis|December 8, 1992

[Drug-induced hyperprolactinemia and galactorrhea]M Bozzolo, W E Haefeli, G Noll, et al.

Journal of Vascular Surgery|April 18, 1998

Functional activity and transmembrane signaling mechanisms after cryopreservation of human internal mammary arteriesE Müller-Schweinitzer, P Stulz, H Striffeler, et al.

The Annals of Pharmacotherapy|January 6, 2001

Seizures associated with therapeutic doses of venlafaxine and trimipramineR G Schlienger, M H Klink, C Eggenberger, et al.

Journal of Vascular Surgery|April 1, 1997

Functional recovery of human mesenteric and coronary arteries after cryopreservation at -196 degrees C in a serum-free mediumE Müller-Schweinitzer, M J Mihatsch, M Schilling, et al.

Journal of Cardiovascular Pharmacology|May 1, 1990

Potent inhibition of cytochrome P450IID6 (debrisoquin 4-hydroxylase) by flecainide in vitro and in vivoW E Haefeli, M J Bargetzi, F Follath, et al.

British Journal of Pharmacology|May 24, 2000

The mechanism of cryoinjury: In vitro studies on human internal mammary arteriesE Müller-Schweinitzer, W Brett, H R Zerkowski, et al.

Pharmacoepidemiology and Drug Safety|April 26, 2007

Optimizing information on drug exposure by collection of package code information in questionnaire surveysR Quinzler, S P W Schmitt, J Szecsenyi, et al.

Pageof 14